CHEMGLAZE M331

Hazard statements (CLP)

H226, H317, H319, H332, H334, H335, H336, H351, H361, H362, H370, H371, H373, H402, H412

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

GHS Classification GHS CLASSIFICATION Flammable liquids Category 3 Acute toxicity Inhalation - Dust and Mist Category 4 - 38.9% of the mixture consists of ingredient(s) of unknown toxicity Serious eye damage/eye irritation Category 2A Skin sensitization Category 1A Respiratory sensitization Category 1 Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ systemic toxicity (single exposure) Category 2 Lungs Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Central nervous system Specific target organ systemic toxicity (repeated exposure) Category 2 Ears Hazardous to the aquatic environment - acute hazard Category 3 Hazardous to the aquatic environment - chronic hazard Category 3

Signal word

DANGER

Hazard statements

Flammable liquid and vapor. Harmful if inhaled. Causes serious eye irritation. May cause an allergic skin reaction. 300000001710 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Suspected of causing cancer. Suspected of damaging fertility or the unborn child. May cause harm to breast-fed children. May cause damage to organs.(Lungs) May cause respiratory irritation. May cause drowsiness or dizziness. Causes damage to organs.(Central nervous system) May cause damage to organs through prolonged or repeated exposure.(Ears) Harmful to aquatic life. Harmful to aquatic life with long lasting effects.

Prevention

Keep away from heat/sparks/open flames/hot surfaces. - No smoking. Ground/Bond container and receiving equipment. Use explosion-proof electrical/ventilating/lighting equipment. Use only non-sparking tools. Take precautionary measures against static discharge. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection. Use personal protective equipment as required. In case of inadequate ventilation wear respiratory protection. Do not breathe dust/fume/gas/mist/vapors/spray. Avoid contact during pregnancy/while nursing. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment.

Response

In case of fire: refer to section 5 of SDS for extinguishing media. Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed: Call a POISON CENTER or doctor/physician. Specific treatment (see supplemental first aid instructions on this label). IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. If skin irritation or rash occurs: Get medical advice/attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Wash contaminated clothing before reuse.

Storage

Store in a well-ventilated place. Keep cool. Store in a well-ventilated place. Keep container tightly closed. Store locked up.

Disposal

Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.

2.3 Other hazards

This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s). Acute: Vapor harmful; may affect the brain or nervous system causing dizziness, headache or nausea. Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. May cause central nervous system depression characterized by the following progressive steps: headache, dizziness, staggering gait, confusion, unconsciousness or coma. Causes skin irritation. Allergic conditions can occur in certain individuals with high sensitivity to isocyanates; this may result in asthma-like symptoms. May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses. Chronic: May cause long-term lung damage. Prolonged or repeated contact may result in dermatitis. Ethylbenzene has been classified by IARC as a possible human carcinogen (Group 2B) and reported by NTP to show clear evidence for carcinogenicity in animals. IARC and NTP have determined that there is sufficient evidence for carcinogenicity of toluene diisocyanate to experimental animals and inadequate evidence in humans. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequate evidence" from human health studies to assess whether carbon black causes cancer in humans. Further, epidemiological evidence from well- conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans. Repeated exposure to n-butyl acetate caused fetotoxic and developmental effects in laboratory animals.

2.1 Classification of the substance or mixture

Flammable liquids Category 3 Acute toxicity Inhalation - Dust and Mist Category 4 - 38.9% of the mixture consists of ingredient(s) of unknown toxicity. Serious eye damage/eye irritation Category 2A Skin sensitization Category 1A Respiratory sensitization Category 1 Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ systemic toxicity (single exposure) Category 2 Lungs Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Central nervous system Specific target organ systemic toxicity (repeated exposure) Category 2 Ears Hazardous to the aquatic environment - acute hazard Category 3 Hazardous to the aquatic environment - chronic hazard Category 3